Difference between revisions of "HIV-1 aspartyl protease (FXIIIa)"
(New page: {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {{infobox header}}| '''{{PAGENAME}}''' |- | align="center" colspan="2...) |
|||
| Line 35: | Line 35: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 10:59, 25 July 2007
| Template:Infobox header| HIV-1 aspartyl protease (FXIIIa) | |
|---|---|
| HIV-1 aspartyl protease (FXIIIa) | |
| Substrate peptide name | HIV-1 aspartyl protease (FXIIIa) |
| Synonyms | - |
| Determination type | In vitro |
| Source | HIV |
| Subcellular localization | HIV |
| Swissprot ID | P04585 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | Not determined yet |
| Substrate sequence | |
| Structure | 1A30 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:1358064 |
| Notes | |
| Template:Infobox header | | |
.png){kind=link}